Lysophosphatidylcholine Acyltransferase1 Overexpression Promotes Oral Squamous Cell Carcinoma Progression via Enhanced Biosynthesis of Platelet-Activating Factor

H Nakanishi, 2006, J Biol Chem, J Biol Chem, 281, 20140

Y Morita, 2013, Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression, J Hepatol, 59, 292, 10.1016/j.jhep.2013.02.030

F Mansilla, 2009, Lysophosphatidylcholine acyltransferase1 (LPCAT1) overexpression in human colorectal cancer, J Mol Med, 87, 85, 10.1007/s00109-008-0409-0

X Zhou, 2012, The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer, Exp Mol Pathol, 92, 105, 10.1016/j.yexmp.2011.11.001

K Grupp, 2013, High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers, Mol Oncol, 7, 1001, 10.1016/j.molonc.2013.07.009

B Xu, 2013, Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers, Br J Cancer, 109, 1279, 10.1038/bjc.2013.480

Y Yamano, 2008, Hyaluronan-mediated motility: a target in oral squamous cell carcinoma, Int J Oncol, 32, 1001

T Harayama, 2008, Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor, J Biol Chem, 283, 11097, 10.1074/jbc.M708909200

H Shindou, 2005, Priming effect of lipopolysaccharide on acetyl-coenzyme A: lyso-platelet-activating factor acyltransferase is MyD88 and TRIF independent, J Immunol, 175, 1177, 10.4049/jimmunol.175.2.1177

H Shindou, 2000, Roles of cytosolic phospholipase A₂ and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF, Biochem Biophys Res Comm, 271, 812, 10.1006/bbrc.2000.2723

H Shindou, 2009, Acyl-CoA: Lysophospholipid acyltransferases, J Biol Chem, 284, 1, 10.1074/jbc.R800046200

CC Yost, 2010, The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses, Biochemie, 92, 692, 10.1016/j.biochi.2010.02.011

JI Fletcher, 2010, ABC transporters in cancer: more than just drug efflux pumps, Nat Rev Cancer, 10, 147, 10.1038/nrc2789

F Taberi, 2007, Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells, Invest Ophthalmol Vis Sci, 48, 1931, 10.1167/iovs.06-1008

V Lukashova, 2003, Janus kinase 2 activation by the platelet activating factor receptor (PAFR): Roles of Tyk2 and PAFR C terminus, J Immunol, 171, 3794, 10.4049/jimmunol.171.7.3794

LS Renteria, 2013, Rho-A kinase and platelet-activating factor stimulation of ovine fetal pulmonary vascular smooth muscle cell proliferation, Cell Prolif, 46, 563, 10.1111/cpr.12052

L Zhang, 2010, Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium, Reprod Biol Endocrinol, 8, 74, 10.1186/1477-7827-8-74

W Zhou, 2007, Platelet-activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation, Am J Physiol, 292, H2773

AB Tsoupras, 2009, The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants, Infect Disord Drug Targets, 9, 390, 10.2174/187152609788922555

Y Endo, 2004, Sarcoendoplasmic reticulum Ca (2+) ATPase type 2 downregulated in human oral squamous cell carcinoma, Int J Cancer, 110, 225, 10.1002/ijc.20118

A Kasamatsu, 2005, Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines, Int J Mol Med, 16, 269

DP Lombardi, 1999, Loss of KAI1 expression in the progression of colorectal cancer, Cancer Res, 59, 5724

K Shimada, 2005, Aberrant expression of RAB1A in human tongue cancer, Br J Cancer, 92, 1915, 10.1038/sj.bjc.6602594

Y Kouzu, 2006, Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumor progression and poor prognosis, Br J Cancer, 94, 717, 10.1038/sj.bjc.6602991

M Iyoda, 2010, PLoS One, PLoS One, 5, e14082

K Sakuma, 2010, Expression status of Zic family member 2 as a prognostic marker for oral squamous cell carcinoma, J Cancer Res Clin Oncol, 136, 553, 10.1007/s00432-009-0689-y

AF Verburg, 2010, Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients, Horm Metab Res, 42, 736, 10.1055/s-0030-1254132

T Onda, 2007, Lin-7C/VELI3/MALS-3: an essential component in metastasis of human squamous cell carcinoma, Cancer Res, 67, 9643, 10.1158/0008-5472.CAN-07-1911

A Yamamoto, 2013, Exocyst complex component Sec8: a presumed component in the progression of human oral squamous- cell carcinoma by secretion of matrix metalloproteinases, J Cancer Res Clin Oncol, 139, 533, 10.1007/s00432-012-1356-2

S Ishii, 2004, Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model, J Immunol, 172, 7095, 10.4049/jimmunol.172.11.7095

RP Sahu, 2014, Platelet-Activating factor receptor and tumor immunity, JSM Cell, 2, 1008

SI de Oliveira, 2010, Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy, BMC Cancer, 10, 200, 10.1186/1471-2407-10-200

B Bussolati, 2000, PAF produced by human breast cancer cell promotes migration and proliferation of tumor cells and neo-angiogenesis, Am J Pathol, 157, 1713, 10.1016/S0002-9440(10)64808-0

M Mathonnet, 2006, Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma, World J Gastroenterol, 12, 2773, 10.3748/wjg.v12.i17.2773

VO Melnikova, 2007, Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor, Cancer Metastasis Rev, 26, 359, 10.1007/s10555-007-9092-9

AC Onuchic, 2012, Expression of PAFR as part of a prosurvival response to chemotherapy: a novel combination therapy in melanoma, M, 17408

VO Melnikova, 2008, Emerging roles of PAR-1 and PAFR in melanoma metastasis, Cancer Microenvironment, 1, 103, 10.1007/s12307-008-0002-7

H Ko, 2002, Nuclear Factor κB dependency of Platelet-activating Factor-induced Angiogenesis, Cancer Res, 62, 1809

HA Kim, 2012, PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis, FEBS Lett, 586, 4296, 10.1016/j.febslet.2012.10.034

PJ Vlachostergios, 2013, The Bmi-1/NF-κB/VEGF story: another hint for proteasome involvement in glioma angiogenesis?, J Cell Commun Signal, 7, 235, 10.1007/s12079-013-0198-2

OM Vladslava, 2009, Crosstalk between prostate-activated receptor1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis, J Biol Chem, 281, 2911

A. Agarwal, 2005, The AKT/IkappaB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappaB and beta-catenin, Oncogene, 24, 1021, 10.1038/sj.onc.1208296

SA Marques, 2002, The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway, J Pharmacol Exp Ther, 300, 1026, 10.1124/jpet.300.3.1026